Brequinar and brequinar analogues in rat allo- and xenotransplantation.
Transplantation Research, Novartis Pharma AG, Basel, Switzerland.
H J
HJ
Schuurman
M
M
Tanner
C
C
Pally
B D
BD
Jaffee
D000818:Animals; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D006224:Cricetinae; D016572:Cyclosporine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008647:Mesocricetus; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D013329:Structure-Activity Relationship; D014183:Transplantation, Heterologous / Q000276:immunology*; D014184:Transplantation, Homologous / Q000276:immunology; D011798:Quinaldines
D001713:Biphenyl Compounds; D016572:Cyclosporine; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; C046943:brequinar; D011798:Quinaldines